‹ Screener

Amneal Pharmaceuticals, Inc.

AMRX · Pharmaceutical Preparations · 319.0M shares · +7%/yr ↑ dilution · EDGAR filings ↗
Net buyback after stock comp: -$27M (gross $5K, SBC $27M)

Reference price $12.94 · est. market cap ~$4.1B — last insider sale, 2026-05-11 (estimated from the dated SEC Form 4 price × shares outstanding — not a live quote)

Grade

B66

Generics + specialty pharma — operationally profitable with strong free cash flow, but high leverage and negative equity.

Strengths

Risks

Notable findings

Quarterly revenue

2025-06-30 · $725M2025-09-30 · $785M2025-12-31 · $814M2026-03-31 · $723M

Last 4 quarters · from SEC filings.

Key metrics

Gross margin
36.9%
Operating margin
13.1%
Net margin
2.4%
Return on equity
-101.8%
Return on assets
2.0%
ROIC
12.5%
Revenue growth (QoQ)
-11.3%
Debt / equity
-36.2×
Current ratio
2.2×
Free cash flow
$270M
Tangible book value
-$1.2B
Cash & investments
$282M
Stock comp / revenue
1.1%

Insider transactions · last 18 months

DateInsiderTypeSharesPrice
2026-05-11Autor Deborah M.Sell35K$12.94
2026-05-07Patel GautamOption exercise35K
2026-05-07Nark Ted COption exercise35K
2026-05-07Yanai ShlomoOption exercise35K
2026-05-07Autor Deborah M.Option exercise35K
2026-05-07Kiely JohnOption exercise35K
2026-05-07George Jeffrey P.Option exercise35K
2026-05-07BUCHI J KEVINOption exercise35K
2026-05-07MEISTER PAUL MOption exercise49K
2026-03-04Konidaris TasosOption exercise44K
2026-03-04Shah NikitaOption exercise36K
2026-03-04Konidaris TasosTax withheld22K$13.30
2026-03-04Shah NikitaTax withheld18K$13.30
2026-03-04Patel ChintuOption exercise93K
2026-03-04Patel ChintuTax withheld29K$13.30
2026-03-04Daly Jason B.Option exercise36K
2026-03-04Daly Jason B.Tax withheld16K$13.30
2026-03-04BOYER ANDREW SOption exercise38K
2026-03-04BOYER ANDREW STax withheld19K$13.30
2026-03-04Patel Chirag K.Option exercise93K
2026-03-04Patel Chirag K.Tax withheld38K$13.30
2026-03-03Konidaris TasosTax withheld14K$13.31
2026-03-03Konidaris TasosOption exercise459K
2026-03-03Konidaris TasosTax withheld230K$13.31
2026-03-03BOYER ANDREW SOption exercise39K
2026-03-03BOYER ANDREW STax withheld20K$13.31
2026-03-03BOYER ANDREW SOption exercise50K
2026-03-03BOYER ANDREW STax withheld25K$13.31
2026-03-03BOYER ANDREW SOption exercise24K
2026-03-03BOYER ANDREW STax withheld12K$13.31
2026-03-03BOYER ANDREW SOption exercise398K
2026-03-03BOYER ANDREW STax withheld199K$13.31
2026-03-03Shah NikitaOption exercise36K
2026-03-03Shah NikitaTax withheld19K$13.31
2026-03-03Shah NikitaOption exercise46K
2026-03-03Shah NikitaTax withheld23K$13.31
2026-03-03Shah NikitaOption exercise24K
2026-03-03Shah NikitaTax withheld12K$13.31
2026-03-03Shah NikitaOption exercise367K
2026-03-03Shah NikitaTax withheld184K$13.31
2026-03-03Patel Chirag K.Tax withheld298K$13.31
2026-03-03Patel ChintuOption exercise60K
2026-03-03Patel ChintuTax withheld17K$13.31
2026-03-03Patel ChintuOption exercise734K
2026-03-03Patel ChintuTax withheld316K$13.31
2026-03-03Patel Chirag K.Option exercise60K
2026-03-03Patel Chirag K.Tax withheld16K$13.31
2026-03-03Patel Chirag K.Option exercise734K
2026-03-03Daly Jason B.Option exercise23K
2026-03-03Daly Jason B.Tax withheld10K$13.31
2026-03-03Daly Jason B.Option exercise38K
2026-03-03Daly Jason B.Tax withheld17K$13.31
2026-03-03Daly Jason B.Option exercise24K
2026-03-03Daly Jason B.Tax withheld11K$13.31
2026-03-03Daly Jason B.Option exercise306K
2026-03-03Daly Jason B.Tax withheld133K$13.31
2026-03-03Konidaris TasosOption exercise45K
2026-03-03Konidaris TasosTax withheld16K$13.31
2026-03-03Konidaris TasosOption exercise57K
2026-03-03Konidaris TasosTax withheld24K$13.31
2026-03-03Konidaris TasosOption exercise29K
2025-11-17Nark Ted CSell50K$11.72
2025-11-12Shah NikitaOption exercise36K$2.75
2025-11-12Shah NikitaOption exercise96K$2.75
2025-11-12Shah NikitaSell132K$11.92
2025-08-27Kiely JohnSell32K$9.23
2025-08-25Shah NikitaSell6.3K$9.50
2025-08-22Shah NikitaSell114K$9.66
2025-08-20BOYER ANDREW SOption exercise175K$2.75
2025-08-20BOYER ANDREW SSell279K$9.38
2025-08-15Konidaris TasosSell219K$9.43
2025-08-14Shah NikitaSell72K$9.29
2025-08-14Konidaris TasosSell119K$9.30
2025-08-13Konidaris TasosSell161K$9.22
2025-08-12Daly Jason B.Sell22K$9.05
2025-08-12Shah NikitaSell50K$9.04
2025-08-12BOYER ANDREW SSell33K$9.05
2025-06-16Patel GautamSell95K$8.02
2025-06-10Patel GautamSell56K$8.02
2025-05-16Shah NikitaSell49K$7.58
2025-05-12Kiely JohnSell50K$7.59
2025-05-05Nark Ted COption exercise40K
2025-05-05Kiely JohnOption exercise40K
2025-05-05George Jeffrey P.Option exercise40K
2025-05-05Alva Emily PetersonOption exercise40K
2025-05-05Patel GautamOption exercise40K
2025-05-05MEISTER PAUL MOption exercise56K
2025-05-05BUCHI J KEVINOption exercise40K
2025-05-05Yanai ShlomoOption exercise40K
2025-05-05Autor Deborah M.Option exercise40K
2025-05-05Patel GautamSell4.9K$8.00
2025-05-02Patel GautamSell3.8K$8.00
2025-04-01Patel GautamSell80K$8.30
2025-03-14Patel Tushar BhikhubhaiSell5.0M$8.35
2025-03-10BUCHI J KEVINGift262K
2025-03-06Daly Jason B.Sell47K$8.73
2025-03-05BOYER ANDREW SSell125K$8.89
2025-03-05Alva Emily PetersonSell80K$8.90
2025-03-05Daly Jason B.Sell43K$8.88
2025-03-05Konidaris TasosSell100K$8.91
2025-03-04Patel ChintuTax withheld47K$8.84
2025-03-04Daly Jason B.Option exercise36K
2025-03-04Daly Jason B.Tax withheld16K$8.84
2025-03-04BOYER ANDREW SOption exercise38K
2025-03-04BOYER ANDREW STax withheld20K$8.84
2025-03-04Konidaris TasosOption exercise44K
2025-03-04Konidaris TasosTax withheld22K$8.84
2025-03-04Patel Chirag K.Option exercise93K
2025-03-04Patel Chirag K.Tax withheld47K$8.84
2025-03-04Patel ChintuOption exercise93K
2025-03-04Shah NikitaOption exercise36K
2025-03-04Shah NikitaTax withheld18K$8.84
2025-03-03BOYER ANDREW STax withheld25K$8.76
2025-03-03BOYER ANDREW STax withheld80K$8.76
2025-03-03Daly Jason B.Tax withheld6.9K$8.76
2025-03-03Daly Jason B.Option exercise38K
2025-03-03Daly Jason B.Tax withheld11K$8.76
2025-03-03Daly Jason B.Option exercise91K
2025-03-03Daly Jason B.Tax withheld31K$8.76
2025-03-03BOYER ANDREW SOption exercise39K
2025-03-03BOYER ANDREW STax withheld20K$8.76
2025-03-03BOYER ANDREW SOption exercise50K
2025-03-03BOYER ANDREW SOption exercise157K
2025-03-03Konidaris TasosOption exercise45K
2025-03-03Konidaris TasosTax withheld16K$8.76
2025-03-03Konidaris TasosOption exercise57K
2025-03-03Konidaris TasosTax withheld24K$8.76
2025-03-03Konidaris TasosOption exercise181K
2025-03-03Konidaris TasosTax withheld93K$8.76
2025-03-03Patel Chirag K.Option exercise580K
2025-03-03Patel Chirag K.Tax withheld280K$8.76
2025-03-03Patel ChintuOption exercise580K
2025-03-03Patel ChintuTax withheld274K$8.76
2025-03-03Daly Jason B.Option exercise23K
2025-03-03Patel GautamSell80K$8.90
2025-03-03Shah NikitaOption exercise36K
2025-03-03Shah NikitaTax withheld19K$8.76
2025-03-03Shah NikitaOption exercise46K
2025-03-03Shah NikitaTax withheld23K$8.76
2025-03-03Shah NikitaOption exercise145K
2025-03-03Shah NikitaTax withheld74K$8.76
2025-03-01BOYER ANDREW SOption exercise31K
2025-03-01BOYER ANDREW STax withheld12K$8.67
2025-03-01Konidaris TasosTax withheld13K$8.67
2025-03-01Shah NikitaOption exercise29K
2025-03-01Shah NikitaTax withheld11K$8.67
2025-03-01Konidaris TasosOption exercise36K
2025-02-03Patel GautamSell80K$8.14
2025-01-08Patel GautamSell63K$8.01
2025-01-02Patel GautamSell17K$8.01

All non-derivative Form 4 activity (SEC), newest first.

Clinical trials

TrialTitlePhaseStatusPrimary completion
NCT06267274 ↗A Randomized, Double-blind, Parallel-group, Two-arm, Multiple Dose, Multicenter, Bioequivalence Study With Clinical Endpoint in the Treatment of Subjects With Chronic Open-angle Glaucoma or Ocular Hypertension in Both Eyes
Open-angle Glaucoma, Ocular Hypertension
PHASE1Recruiting2025-03-01
NCT02110368 ↗Bioequivalence Study of Test and Reference Testosterone Topical Gel, 1.62% Metered Pump in Testosterone Deficient Adult Male Subjects Under Fasting Conditions
Primary Hypogonadism, Hypogonadotropic Hypogonadism
PHASE3Completed2014-03-01
NCT01064024 ↗Evaluate the Safety and Efficacy of Phenazopyridine Hydrochloride Tablets, USP 200 mg vs. Placebo
Pain, Urinary Tract Infections
PHASE3Completed2010-12-01

Source: ClinicalTrials.gov (U.S. NIH) · active studies first.

Notable events (8-K)

DateItems
2026-05-07ResultsExhibitsfiling ↗
2026-05-07Shareholder votefiling ↗
2026-04-22Material agreementResults3.02Reg FDExhibitsfiling ↗
2026-02-27ResultsReg FDExhibitsfiling ↗
2026-02-03Material agreementDebt obligationfiling ↗
2026-01-28Otherfiling ↗
2026-01-13ResultsReg FDfiling ↗
2025-10-30ResultsReg FDExhibitsfiling ↗

Recent filings

FormFiledPeriodAccession
10-Q2026-05-072026-03-310001723128-26-000020 ↗
8-K2026-05-072026-05-070001723128-26-000019 ↗
8-K2026-05-072026-05-060001628280-26-032137 ↗
8-K2026-04-222026-04-220001193125-26-168231 ↗
10-K2026-02-272025-12-310001723128-26-000011 ↗
8-K2026-02-272026-02-270001723128-26-000008 ↗
8-K2026-02-032026-02-020001628280-26-004738 ↗
8-K2026-01-282026-01-230001628280-26-003842 ↗
8-K2026-01-132026-01-130001723128-26-000003 ↗
10-Q2025-11-062025-09-300001723128-25-000062 ↗
8-K2025-10-302025-10-300001723128-25-000059 ↗
10-Q2025-08-072025-06-300001723128-25-000047 ↗